DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,262,213 shares of the medical instruments supplier’s stock after selling 140,897 shares during the quarter. Bank of New York Mellon Corp owned about 1.14% of DENTSPLY SIRONA worth $33,797,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. increased its stake in shares of DENTSPLY SIRONA by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock worth $383,078,000 after acquiring an additional 65,478 shares during the period. Nuance Investments LLC increased its stake in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after acquiring an additional 1,975,404 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in shares of DENTSPLY SIRONA by 2.8% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock worth $219,018,000 after acquiring an additional 314,343 shares during the period. Finally, Lazard Asset Management LLC increased its stake in shares of DENTSPLY SIRONA by 23.0% in the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier’s stock worth $152,678,000 after acquiring an additional 1,505,928 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Down 0.5%

Shares of NASDAQ:XRAY opened at $15.92 on Wednesday. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.95. The company has a 50 day moving average of $16.04 and a two-hundred day moving average of $16.34. The company has a market capitalization of $3.17 billion, a price-to-earnings ratio of -3.51, a price-to-earnings-growth ratio of 1.14 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same quarter last year, the company earned $0.42 earnings per share. The business’s quarterly revenue was down 7.8% compared to the same quarter last year. As a group, analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.02%. The ex-dividend date of this dividend was Friday, June 27th. DENTSPLY SIRONA’s payout ratio is -14.10%.

Wall Street Analyst Weigh In

XRAY has been the topic of several recent analyst reports. Wall Street Zen raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Sunday. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target on the stock. in a research note on Tuesday, April 15th. UBS Group cut their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a research report on Friday, May 9th. Barrington Research raised their price objective on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Monday, May 12th. Finally, Piper Sandler cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research report on Wednesday, April 30th. Eleven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.